UAB Wellgem Biopharma Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
139,741 |
49,032 |
123,360 |
-123,360 |
-43,284 |
-2.93 |
-53.06 |
7.40 |
-88.28 |
-28,858 |
1,531,301 |
1,416,081 |
85,962 |
2023 |
---|
298,561 |
44,964 |
-309,729 |
-309,729 |
-46,646 |
0.59 |
-6.02 |
93.13 |
-103.74 |
-332,427 |
1,999,702 |
1,480,036 |
185,537 |
2024 |
---|
137,620 |
14,456 |
-419,214 |
-419,214 |
-44,035 |
2.83 |
-9.65 |
-6.75 |
-304.62 |
-751,641 |
7,251,641 |
4,223,088 |
2,375,290 |
Register and
explore Okredo data2024 |
---|
137,620 |
14,456 |
-419,214 |
-419,214 |
-44,035 |
2.83 |
-9.65 |
-6.75 |
-304.62 |
-751,641 |
7,251,641 |
4,223,088 |
2,375,290 |
Register and
explore Okredo data2024
Turnover (€)
137,620 €-54 % *
Sales per employee (€)
14,456 €-68 % *
Profit before tax (€)
-419,214 €-35 % *
Net Profit (€)
-419,214 €-35 % *
Profit per employee (€)
-44,035 €6 % *
Working capital requirement
2.83 379.66 % *
Debt-to-equity ratio
-9.65 -60.30 % *
Total profitability (%)
-6.75 %-107.25 % *
Net profitability (%)
-304.62 %-193.64 % *
Equity (€)
-751,641 €-126 % *
Amounts Payable And Liabilities (€)
7,251,641 €263 % *
Non-current Assets (€)
4,223,088 €185 % *
CurrentAssets (€)
2,375,290 €1,180 % *